Patent · US Active

Methods and compositions relating to anti-IL-21 receptor antibodies

US10184002B2 · kind B2 · utility

0Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 1, 2016
Grant dateJan 22, 2019
Priority date
Expiry dateMar 1, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods relating to antigen binding proteins against IL-21 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.